These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21460033)

  • 1. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.
    Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
    Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
    Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
    Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human breast lesions: characterization with proton MR spectroscopy.
    Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
    Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
    Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
    Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary gland tumors at in vivo proton MR spectroscopy.
    King AD; Yeung DK; Ahuja AT; Tse GM; Yuen HY; Wong KT; van Hasselt AC
    Radiology; 2005 Nov; 237(2):563-9. PubMed ID: 16244265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy.
    Bartella L; Thakur SB; Morris EA; Dershaw DD; Huang W; Chough E; Cruz MC; Liberman L
    Radiology; 2007 Oct; 245(1):80-7. PubMed ID: 17885182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results.
    Yeung DK; Cheung HS; Tse GM
    Radiology; 2001 Jul; 220(1):40-6. PubMed ID: 11425970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.
    Dorrius MD; Pijnappel RM; van der Weide Jansen MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
    Eur Radiol; 2012 Apr; 22(4):915-22. PubMed ID: 22076317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative multivoxel proton chemical shift imaging of the breast.
    Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M
    Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
    Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
    J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
    Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
    AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
    Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
    NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal masses: characterization with in vivo proton MR spectroscopy--initial experience.
    Faria JF; Goldman SM; Szejnfeld J; Melo H; Kater C; Kenney P; Huayllas MP; Demarchi G; Francisco VV; Andreoni C; Srougi M; Ortiz V; Abdalla N
    Radiology; 2007 Dec; 245(3):788-97. PubMed ID: 18024453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.
    Thakur SB; Brennan SB; Ishill NM; Morris EA; Liberman L; Dershaw DD; Bartella L; Koutcher JA; Huang W
    J Magn Reson Imaging; 2011 Apr; 33(4):855-63. PubMed ID: 21448950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
    Mackinnon WB; Barry PA; Malycha PL; Gillett DJ; Russell P; Lean CL; Doran ST; Barraclough BH; Bilous M; Mountford CE
    Radiology; 1997 Sep; 204(3):661-6. PubMed ID: 9280241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
    J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.